9 /100
LOW RISK
Score updated Jul 13, 2026

MET — MetLife, Inc. Dilution Risk Tracker

Track MET dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MET — Get alerts when the score changes →

As of July 13, 2026, MetLife, Inc. (MET) has a DilutionWatch DilutionScore of 9/100, rated LOW dilution risk. MetLife, Inc. has a market capitalization of $53.21B, 643.44M shares outstanding, 1389 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
17
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for MET.
🔔 Track MET — Get forecast alerts →

💹 Market Data

Market Cap$53.21B
Shares Outstanding643.44M
Float537.55M
Cash$27.64B
Debt$19.28B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 23.1% shares (2026Q1 vs prior)
1389 institutional holders · 637.19M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 71.71M shares
#2 BlackRock, Inc. 51.42M shares
#3 Dodge & Cox 51.11M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest14.29M
Days to Cover3.1
% of Float2.7%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Apr 03, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for MET Shareholders

MetLife, Inc. (MET) has a DilutionScore of 9/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for MET shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for MET in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for MET alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track MET Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MET — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for MET
📊 MET FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MET Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.